PRESS RELEASE:

Gujarat to get Zonal office of Drug Controller of India for speedy clearances
Registration of organization involved in Clinical research (CROs) will be
soon mandatory

The 3-day InformEx India 2009 begins in Ahmedabad

Ahmedabad, March 12th, 2009

" Keeping in view the concentration of pharmaceutical, medical devices and growing clinical research organizations in the state, the central government has decided to upgrade the status of Drug Controller office in Gujarat region to Zonal office. This would mean lot of convenience and speedy clearance, and approval for the pharmaceutical, medical devices and clinical research industry based in Gujarat ." announced Mr Surinder Singh, Drug Controller general of India from New Delhi, at the opening session of 3-day premier Exhibition & Network Event for Fine and Specialty Chemicals and Pharmaceuticals industries, 'InformExIndia 2009' which began today at the University Grounds in Ahmedabad.

Mr. Singh, who was guest of honour at the event elaborated upon the measures that central government has initiated to to streamline the procedures for government clearances and approval for pharmaceutical and medical devices industry, as well as to ensure patient safety and safe clinical research practices.

Mr. Singh said that DCGI office was working hard to implement best regulatory practices in medical, bio-medical and medical devices industry. He urged the industry to 'adapt' the global trends and practices in order to survive in the competitive times.

Talking about the various initiatives that DCGI office has taken to improve the working of Mr Singh informed that 62 more posts of drug inspectors have been cleared which help in speedy clearing of procedures.

Mr Singh further stated that in order to bring more safety and transparency, registration of all the organizations involved in Clinical trails and research will be made mandatory and such organization will be audited adherence of protocols and laid down procedures for patient safety. He also informed that a registry of Clinical research organization will be made which will have important data like design of CR, target and sponsors details etc.

He announced that soon in consultation with Medical council of India , Pharmaco vigilance centers will be established in select medical colleges of India which will oversee the various aspects of safety and adherence of guidelines. The e-governance initiatives are also being stepped up to increase transparency in the procedures and clearances, encourage adaptation best practices in global environment.

InformEx India is the first and only incarnation of InformEx outside of USA , which has a 25 year history of serving manufacturers and buyers of specialty and fine chemicals from all over the world.

The event is spread in a 40,000 sq. ft. thoroughly air-conditioned exhibition area, was inaugurated by the Chief Guest, Mr. D Rajagopalan, Chief Secretary, Government of Gujarat. a host of national and international dignitaries from the chemical & pharmaceutical industry and senior officials from the government. The Indian Chemical Council (ICC) will organize a conference on chemicals - 'Survival in Slowdown', wherein the key speakers will be Mr. Ravi Kapoor - M.D, Heubach Colour, Dr. Nabar - V.P, Clariant Chemicals and eminent Financial Expert, Mr. Milin Mehta.

More then 1000 participants have already registered from all over India and countries like USA , Japan , Singapore , South Africa and other Asian countries. InformEx India is slated to draw more than 3000 visitors in 3 days.

More than 100 top Chemical & Pharmaceutical companies of the likes of Zydus Cadilla, Deepak Nitrite Ltd., Cadilla Pharma, Sanofi Aventis, JB Chemicals & Pharmaceuticals, Torrent Pharma, Meghmani Group, Sun Pharma, Aarti Industries and Sajjan Chemicals, Sterling , Norris Medicines, Intas Pharma will participate in the exhibition.

InformEX India - as the name suggests is an "Information Exchange" between buyers and vendors with specific needs and skills.   The exhibitors pride themselves in their specialist knowledge and abilities to be able to manipulate molecules to vary exact purpose.

Mr. Pankaj Patel, Chairman of advisory committee of InformEx 2009, and CMD, Zydus Cadila, while welcoming the delegates and exhibitors, said the event is rightfully being held in Gujarat as the state is going to be the most beneficiary since it has the large capabilities in manufacturing, product development and other areas of chemical and pharmaceutical industry as well as Research hub of the same. Events like Informex will strengthen the industry, allowing opportunities of networking and business growth besides learning from the global counterparts.

India with it's reputation for academic excellence in chemistry and its imposing stature for having more FDA approved sites outside of the USA than any other country, is a natural choice for a new InformEX. And thus the next edition of InformEx India will be held in 2011, and promises to become a regular calendar event for Gujarat, further enhancing its position as an invincible Chemical and Pharmaceutical hub' Mr M Gandhi, managing director of UBM Indian said.

Prestigious Industrial associations have very enthusiastically extended their cooperation and support for the Event. These are IDMA, Chemexcil, Pharmexcil, CAMA, ICC, ISCMA, BDMA and also international associations like SOCMA - USA , CCPIT China & KSCIA - Korea .
 
With a tagline which says 'Chemistry you won't find anywhere else' InformEx India is sure to boost InformexINDIA is organized by UBM India Pvt. Ltd., the largest private trade exhibition organizer in India . It organizes more than 300 Exhibition worldwide and has many reputed events in their portfolio, including the biggest pharma event CPhI India

For further information, please

contact:

Aarat Sheth - 98982 98304

13th March 2009 Friday parallel sessions

Panel Discussion on

"Scenario of Pharma Industry - Present & Future"

13th March 2009 10.30 am onwards

Distinguished Panelists:

Mr. Ashok Kumar, IAS

Secretary Pharma, Government of India

"Regulatory issues, the new Pharma policy, what does the Government expect from Industry"

Mr. Pankaj Patel

CMD, Zydus Cadila

"Indian Pharma Industry's Competitiveness and Future in the world market."

Dr. P V Appaji

Executive Director

Pharmexcil

As Pharmexcil is a bridge between industry and Government, "what are the facilities offered by Pharmexcil to industry and how industry can avail of these."

Moderator :

Ms. Viveka Roychowdhury

Editor

Express Pharma

Conference on Chemical by ICC - Indian Chemical Council

13th March 2009 10.30 am onwards

Prominent Speakers from Industry will be giving their presentation on "Current Economic Slow Down and steps to Over Come it"

Mr. Ravi Kapoor, MD, Heubach Colours

Dr. Uday Nabar, VP, Clariant Chemicals

Mr. Milin Mehta , CA , K C Mehta & Sons

Mr. Vinayak Natu, Expert & Consultant in Nanotechnology

Exhibitors List

• Zydus Cadila .
• Nirma Ltd.
• Intas Pharmaceuticals Ltd.
• Sun Pharmaceuticals Ltd.
• Rashtriya Chemicals & Fertilizers Ltd.
• Torrent Pharmaceuticals Ltd.
• Guajrat Alkalies & Chemicals Ltd.
• GSFC - Gujarat State Fertilisers Corporation Ltd.
• Cadila Pharmaceuticals Ltd.
• Concord Biotech Ltd. Famycare Ltd.
• Korea International Business Corporation.
• Aarti Industries Ltd.
• J BChemicals and Pharmaceuticals Ltd.
• Jubiliant Infrastructure Ltd.
• Deepak Nitrite Ltd.
• Rallis India Ltd.
• Sterling Auxiliaries. Indofil Chemicals Co.
• United Phosphorus Ltd.
• Sajjan Speciality Chemicals Ltd